Skip to main content

ELTROMBOPAG

NDC 70771-1927 · Zydus Lifesciences Limited

Generic nameeltrombopag
Dosage formTABLET
RouteORAL
Active ingredient(s)ELTROMBOPAG OLAMINE
Strength50 mg/1
Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
Marketing categoryANDA

Packages

70771-1927-3 — 30 TABLET in 1 BOTTLE (70771-1927-3)

70771-1927-7 — 14 TABLET in 1 BOTTLE (70771-1927-7)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70069-837 — Eltrombopag olamine, 70069-838 — Eltrombopag olamine, 70069-839 — Eltrombopag olamine, 70069-840 — Eltrombopag olamine, 70710-1395 — eltrombopag, 70710-1396 — eltrombopag, 70710-1397 — eltrombopag, 70710-1398 — eltrombopag, 70771-1925 — eltrombopag, 70771-1926 — eltrombopag, 70771-1928 — eltrombopag, 72205-156 — eltrombopag olamine, 72205-157 — eltrombopag olamine, 72205-158 — eltrombopag olamine, 72205-159 — eltrombopag olamine, 72865-299 — ELTROMBOPAG, 72865-300 — ELTROMBOPAG, 72865-301 — ELTROMBOPAG, 72865-302 — ELTROMBOPAG, 87564-032 — Eltrombopag olamine, +35 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.